CAS 51333-22-3
:Budesonide
Description:
Budesonide is a synthetic corticosteroid with anti-inflammatory properties, primarily used in the treatment of asthma and allergic rhinitis, as well as inflammatory bowel diseases like Crohn's disease and ulcerative colitis. It functions by inhibiting the release of inflammatory mediators and modulating immune responses. Budesonide is characterized by its high lipophilicity, which enhances its local anti-inflammatory effects while minimizing systemic absorption when administered via inhalation or intranasal routes. The substance is typically formulated as an aerosol, nebulizer solution, or nasal spray, allowing for targeted delivery to the respiratory or nasal mucosa. Budesonide has a relatively short half-life, necessitating multiple daily doses for optimal therapeutic effect. Its safety profile is generally favorable, with common side effects including local irritation and, less frequently, systemic effects associated with long-term use. Overall, budesonide is an effective medication for managing chronic inflammatory conditions, providing relief from symptoms while minimizing potential adverse effects when used appropriately.
Formula:C25H34O6
InChI:InChI=1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1
InChI key:InChIKey=VOVIALXJUBGFJZ-KWVAZRHASA-N
SMILES:C(CO)(=O)[C@]12[C@]3(C)[C@@](C[C@]1(OC(CCC)O2)[H])([C@]4([C@]([C@@H](O)C3)([C@]5(C)C(CC4)=CC(=O)C=C5)[H])[H])[H]
Synonyms:- (11β,16α)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
- (4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
- (4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
- 16α,17α-(Butylidenedioxy)-11β,21-dihydroxypregna-1,4-diene-3,20-dione
- 2H-Naphth[2′,1′:4,5]indeno[1,2-d][1,3]dioxole, pregna-1,4-diene-3,20-dione deriv.
- Barazone
- Bidien
- Budecort Aqua
- Budenofalk
- Budes
- Budesomide
- Budeson
- Budesonid
- Budesonida
- Budesonide
- Budesonide MMX
- Budesonido
- Bunesonide
- Cortivent
- Entocort
- Jorveza
- Micronyl
- Nebuampul
- Novopulmon
- Preferid
- Pregna-1,4-diene-3,20-dione, 16,17-[butylidenebis(oxy)]-11,21-dihydroxy-, (11β,16α)-
- Pulmicort
- Respules
- Rhinocort
- Rhinocort Aqua
- Rhinocort respules
- S 1320
- Spirocort
- Turbuhaler
- Uceris
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 20 products.
Budesonide
CAS:Formula:C25H34O6Purity:>98.0%(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:430.54BUDESONIDE FOR SYSTEM SUITABILITY CRS
CAS:BUDESONIDE FOR SYSTEM SUITABILITY CRSFormula:C25H34O6Molecular weight:430.5339Budesonide
CAS:Adrenal cortical hormones and their derivatives nesoiFormula:C25H34O6Color and Shape:White PowderMolecular weight:430.23554Budesonide
CAS:Budesonide (Pulmicort), an anti-inflammatory corticosteroid, has shown the effective glucocorticoid activitie and few mineralocorticoid activities. According to reports, Budesonide has extensively inhibitory effects against multiple cells types and mediators referred to allergic and nonallergic-mediated inflammatory. What's more, the anti-inflammatory action of budesonide has been revealed to contribute to the effectiveness of asthma.Formula:C25H34O6Purity:99.03% - 99.72%Color and Shape:Crystals SolidMolecular weight:430.53Budesonide
CAS:Formula:C25H34O6Purity:≤ 0.5%Color and Shape:White crystalline powderMolecular weight:430.53Budesonide (Mixture of Diastereomers)
CAS:Formula:C25H34O6Color and Shape:White To Off-White SolidMolecular weight:430.54GB/T 24800.2-2009 41 Glucocorticoids 100 µg/mL in Methanol
CAS:Controlled Product- 105102-22-5
- 1177-87-3
- 124-94-7
- 13609-67-1
- 14484-47-0
- 1524-88-5
- 2135-17-3
- 2152-44-5
- 25122-46-7
- 25122-57-0
- 3093-35-4
- 33564-31-7
- 356-12-7
- 378-44-9
- 3801-06-7
- 3870-07-3
- 426-13-1
- 4419-39-0
- 50-02-2
- 50-03-3
- 50-04-4
- 50-23-7
- 50-24-8
- 51022-69-6
- 51333-22-3
- 514-36-3
- 53-06-5
- 5534-09-8
- 5593-20-4
- 57524-89-7
- 66734-13-2
- 67-78-7
- 73771-04-7
- 76-25-5
- 80474-14-2
- 83-43-2
- 987-24-6
Color and Shape:MixtureBudesonide 100 µg/mL in Acetonitrile
CAS:Formula:C25H34O6Color and Shape:Single SolutionMolecular weight:430.53Budesonide - Bio-X ™
CAS:Controlled Product<p>Budesonide is a glucocorticoid receptor drug that is used to treat inflammatory diseases of the lungs such as COPD, Crohn’s disease and asthma. This drug promotes anti-inflammatory genes such as interleukin-10. Budesonide aims to reduce inflammation in patients suffering from respiratory disease.</p>Formula:C25H34O6Purity:Min. 95%Color and Shape:PowderMolecular weight:430.53 g/molBudesonide
CAS:Controlled Product<p>Glucocorticoid receptor agonist; anti-inflammatory</p>Formula:C25H34O6Purity:Min. 95%Color and Shape:White Off-White PowderMolecular weight:430.53 g/molDes-(2-propyl-1,3-dioxolane)-2-hydroxy Budesonide
CAS:Controlled ProductFormula:C21H26O5Color and Shape:NeatMolecular weight:358.428Budesonide - IP
CAS:Controlled Product<p>Budesonide is a corticosteroid that is used to treat asthma, and also to reduce inflammation in the airways. It belongs to a class of drugs called inhaled corticosteroids, which are used for the treatment of asthma. Budesonide reduces inflammation by inhibiting the release of inflammatory substances such as eosinophil cationic protein and chronic cough. It has been shown in clinical studies that budesonide can be effective in treating chronic bacterial rhinosinusitis caused by bacteria such as Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis. This drug has also been shown to have anti-inflammatory activity against bacteria such as Pseudomonas aeruginosa.</p>Formula:C25H34O6Purity:Min. 95%Color and Shape:PowderMolecular weight:430.53 g/mol
